BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
180 results:

  • 1. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
    Liu B; Liu XY; Wang GP; Chen YX
    Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
    Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
    Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders.
    Bertrand A; Ba I; Kermasson L; Pirabakaran V; Chable N; Lainey E; Ménard C; Kallel F; Picard C; Hadiji S; Coolen-Allou N; Blanchard E; de Villartay JP; Moshous D; Roelens M; Callebaut I; Kannengiesser C; Revy P
    Hum Mol Genet; 2024 Mar; 33(7):612-623. PubMed ID: 38176734
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. T-cell lymphocytes' aging clock: telomeres, telomerase and aging.
    Chebly A; Khalil C; Kuzyk A; Beylot-Barry M; Chevret E
    Biogerontology; 2024 Apr; 25(2):279-288. PubMed ID: 37917220
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients.
    Shi Y; Wu S; Zhang X; Cao Y; Zhang L
    J Gene Med; 2024 Jan; 26(1):e3613. PubMed ID: 37861176
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EMAS position statement: Testosterone replacement therapy in older men.
    Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
    Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic Aspects of Conjunctival Melanoma: A Review.
    Chang E; Demirci H; Demirci FY
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ATRX Loss in the Development and Prognosis of Conjunctival Melanoma.
    van Ipenburg JA; van den Bosch QCC; Paridaens D; Dubbink HJ; Kiliç E; Naus N; Verdijk RM;
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629169
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.
    Borzone FR; Giorello MB; Martinez LM; Sanmartin MC; Feldman L; Dimase F; Batagelj E; Yannarelli G; Chasseing NA
    Oncol Res; 2023; 31(3):361-374. PubMed ID: 37305388
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
    Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
    Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.
    Park S; Yun J; Choi SY; Jeong D; Gu JY; Lee JS; Seong MW; Chang YH; Yun H; Kim HK
    Sci Rep; 2023 May; 13(1):7280. PubMed ID: 37142644
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
    Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
    Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Distinct IDH1/2-associated Methylation Profile and Enrichment of
    Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
    Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expanding the Spectrum of
    De Leo A; Serban D; Maloberti T; Sanza V; Coluccelli S; Altimari A; Gruppioni E; Chiarucci F; Corradini AG; Repaci A; Colapinto A; Nannini M; Pantaleo MA; de Biase D; Tallini G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835466
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
    Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
    Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma.
    Yue Z; Gao C; Xing T; Zhao W; Duan C; Wang X; Jin M; Su Y
    Pediatr Blood Cancer; 2023 May; 70(5):e30261. PubMed ID: 36815592
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
    Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
    Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pan-cancer analysis of tert and Validation in Osteosarcoma Cell Lines.
    Xie L; Yin W; Tang F; He M
    Biochem Biophys Res Commun; 2023 Jan; 639():106-116. PubMed ID: 36476950
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.